262 results on '"Shiroiwa T"'
Search Results
2. Institutional care versus home care for the elderly in a rural area: Cost comparison in rural Japan
3. Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report : reliability and construct validity
4. PCR164 Feasibility and Validation of the Japanese Version of the EQ-HWB
5. Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
6. POSA381 Health State Utility Values for Metastatic Pancreatic Cancer in Japan, Based on the Vignette-Based Approach
7. PCR102 Relationship between Health-State Utility Values, Self-Efficacy, and Health Locus of Control in the General Population
8. PNS394 DEVELOPMENT OF A MULTIPLICATIVE MULTI-ATTRIBUTE AND SINGLE-ATTRIBUTE UTILITY FUNCTION FOR THE HUI3 IN JAPAN
9. PNS185 RELATIONSHIP BETWEEN PARTIAL VALUES AND SCORING SCALE FOR EACH CRITERION OF THE EVIDEM 10TH EDITION CORE MODEL IN JAPAN
10. PNS323 WHAT IS A VALID MAPPING ALGORISM IN COST-UTILITY ANALYSES? AN ANSWER FROM A MISSING DATA PERSPECTIVE
11. Cultural Values: Can They Explain Differences in Health Utilities between Countries?
12. PHP86 - IMPORTANCE OF CRITERIA FOR DRUG REIMBURSEMENT DECISION-MAKING FOR NON-LIFE-THREATENING DISEASES
13. PMU94 - DEVELOPMENT OF JAPANESE PREFERENCE WEIGHT FOR THE ADULT SOCIAL CARE OUTCOMES TOOLKIT (ASCOT) SCT4
14. PCN377 - RESPONSE SHIFT EFFECT ON QUALITY OF LIFE IN RANDOMIZED CONTROL TRIAL OF TAXANE VERSUS S-1 FOR METASTATIC BREAST CANCER PATIENTS (SELECT-BC): STRUCTURAL EQUATION MODELING
15. Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan
16. The EQ-5D Index of Elderly Patients with HER2-Positive Breast Cancer: Results from the Randomized N-SAS BC 07 Trial for Adjuvant Trastuzumab with and without Chemotherapy
17. Comparison Of Elderly Care Recipients’ Social Care-Related Quality Of Life (SCRQOL) With Health Related Quality Of Life (HRQOL) In Japan
18. Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan
19. Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results From Randomized Phase III Select BC Study
20. Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes: An Analysis Based on the Randomized Phase III Select BC Trial
21. Productivity Loss of Cancer Patients in Japan
22. Comparison Between Eq-5d And Hui In Japanese Population Norms
23. Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan
24. Trends in Japanese Clinical Trial Registration from 2005 to 2014
25. Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
26. PCV47 - Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan
27. PCN65 - The EQ-5D Index of Elderly Patients with HER2-Positive Breast Cancer: Results from the Randomized N-SAS BC 07 Trial for Adjuvant Trastuzumab with and without Chemotherapy
28. Japanese Population Norms for Preference-Based Measures: Eq-5d-3l, Eq-5d-5l, And Sf-6d
29. Long-Term Eq-5d Score For Patients With Metastatic Breast Cancer; Comparison Of First-Line Oral S-1 And Taxane Therapies In The Randomized “Select” Trial
30. Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients
31. Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints
32. P-247 A follow-up results of team management approach for XELOX therapy in patients with advanced/recurrent colorectal cancer: the SMILE Study (Study of Metastatic colorectal cancer to investigate Impact of Learning Effect)
33. PHP179 - Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan
34. PHS64 - Comparison Of Elderly Care Recipients’ Social Care-Related Quality Of Life (SCRQOL) With Health Related Quality Of Life (HRQOL) In Japan
35. Treatment Costs for Breast Cancer in Japan: Large Claim Database Analysis
36. A Comparison of Value for Health States Worse Than Dead Between Japan and Uk
37. Medical Expenditures Associated With Type 2 Diabetes Mellitus in Japan: A Large Claims Database Study
38. Assessment of Response Shift and True Change Using Structural Equation Modeling for Health–Related Quality-of-Life Scores in Patients with Breast Cancer After Surgery
39. Reanalysis of Cost-Effectiveness of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer in Japan Using a Japanese Claim Data Set
40. PCN204 - Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results From Randomized Phase III Select BC Study
41. PCN183 - Productivity Loss of Cancer Patients in Japan
42. PCN161 - Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes: An Analysis Based on the Randomized Phase III Select BC Trial
43. PIH25 - Comparison Between Eq-5d And Hui In Japanese Population Norms
44. PHP86 - Trends in Japanese Clinical Trial Registration from 2005 to 2014
45. PHP107 - Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan
46. Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan
47. Proposal of Economic Evaluation Guideline in Japan
48. Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice Study
49. Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?
50. Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.